The Effects of IABP Prior to Revascularization on Mortality of ACS Patients Complicated With Cardiogenic Shock

Clinical Trial ID NCT03635840

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03635840

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012 9.22
2 Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999 6.93
3 Circulatory shock. N Engl J Med 2013 4.95
4 A tale of coronary artery disease and myocardial infarction. N Engl J Med 2012 4.53
5 A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009 3.06
6 In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005 2.71
7 Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009 2.60
8 Cardiogenic shock: current concepts and improving outcomes. Circulation 2008 2.60
9 Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006 2.35
10 The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001 2.01
11 Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development. Eur Heart J 2003 1.66
12 Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation 2008 1.47
13 Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch Arztebl Int 2012 1.06
14 Augmentation of regional coronary blood flow by intra-aortic balloon counterpulsation in patients with unstable angina. Circulation 1983 0.94
15 Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2010 0.94
16 Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol 1999 0.87
17 Lactate and lactate clearance in acute cardiac care patients. Eur Heart J Acute Cardiovasc Care 2012 0.85
18 Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials. Acute Card Care 2011 0.75
19 Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation. Med Klin Intensivmed Notfmed 2015 0.75
20 Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial. Int J Cardiol 2015 0.75
21 Have we given up on intra-aortic balloon counterpulsation in post-myocardial infarction cardiogenic shock? Clin Cardiol 2013 0.75
Next 100